Valuation Bristol-Myers Squibb Company Lima

Stocks

Real-time Estimate Cboe BZX 15:59:59 2026-08-17 EDT			5-day change	1st Jan Change
64.65 ^USD	+1.54%		-2.75%	+18.21%

02:13am	AstraZeneca suffers another setback as it halts volrustomig lung cancer trial	RE
11:30pm	Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	138,395	159,703	104,403	114,714	109,809	130,386	-	-
Change	-	15.4%	-34.63%	9.88%	-4.28%	18.74%	-	-
Enterprise Value (EV) ¹	165,982	189,770	131,531	153,184	143,852	159,126	152,159	146,512
Change	-	14.33%	-30.69%	16.46%	-6.09%	10.62%	-4.38%	-3.71%
P/E	20x	24.4x	13.3x	-12.8x	15.6x	11.4x	11.3x	13x
PBR	3.73x	5.02x	3.48x	6.95x	5.94x	5.36x	4.39x	3.94x
PEG	-	-4.48x	0.4x	0x	-0x	0.2x	34.7x	-1x
Capitalization / Revenue	2.98x	3.46x	2.32x	2.38x	2.28x	2.62x	2.71x	3.1x
EV / Revenue	3.58x	4.11x	2.92x	3.17x	2.98x	3.19x	3.16x	3.48x
EV / EBITDA	8.1x	9.83x	7.52x	25.8x	7.71x	8.28x	8.27x	9.29x
EV / EBIT	8.37x	9.76x	7.84x	29.4x	9.83x	8.98x	8.91x	9.94x
EV / FCF	10.9x	15.9x	10.4x	11x	11.2x	14.2x	11.2x	11.3x
FCF Yield	9.18%	6.3%	9.62%	9.1%	8.93%	7.05%	8.92%	8.87%
Dividend per Share ²	2.01	2.19	2.31	2.42	2.49	2.527	2.57	2.633
Rate of return	3.22%	3.04%	4.5%	4.28%	4.62%	3.96%	4.03%	4.12%
EPS ²	3.12	2.95	3.86	-4.41	3.46	5.613	5.632	4.891
Distribution rate	64.4%	74.2%	59.8%	-54.9%	72%	45%	45.6%	53.8%
Net sales ¹	46,385	46,159	45,006	48,300	48,194	49,848	48,133	42,044
EBITDA ¹	20,493	19,308	17,498	5,932	18,649	19,213	18,389	15,764
EBIT ¹	19,830	19,442	16,785	5,204	14,638	17,722	17,085	14,744
Net income ¹	6,994	6,327	8,025	-8,948	7,054	11,176	10,517	8,962
Net Debt ¹	27,587	30,067	27,128	38,470	34,043	28,739	21,773	16,125
Reference price ²	62.35	71.95	51.31	56.56	53.94	63.83	63.83	63.83
Nbr of stocks (in thousands)	2,219,645	2,219,645	2,034,758	2,028,177	2,035,753	2,042,715	-	-
Announcement Date	2/4/22	2/2/23	2/2/24	2/6/25	2/5/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
Average	17.00x	6.46x	15.43x	2.43%	399.46B
Weighted average by Cap.	24.17x	8.04x	17.73x	2%